CA2020794A1 - Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament - Google Patents

Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament

Info

Publication number
CA2020794A1
CA2020794A1 CA002020794A CA2020794A CA2020794A1 CA 2020794 A1 CA2020794 A1 CA 2020794A1 CA 002020794 A CA002020794 A CA 002020794A CA 2020794 A CA2020794 A CA 2020794A CA 2020794 A1 CA2020794 A1 CA 2020794A1
Authority
CA
Canada
Prior art keywords
galactan
klebsiella
high performance
comes
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002020794A
Other languages
English (en)
French (fr)
Inventor
Pierre Smets
Rene Zalisz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of CA2020794A1 publication Critical patent/CA2020794A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002020794A 1989-07-11 1990-07-10 Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament Abandoned CA2020794A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8909305 1989-07-11
FR8909305A FR2650506B1 (fr) 1989-07-11 1989-07-11 Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament

Publications (1)

Publication Number Publication Date
CA2020794A1 true CA2020794A1 (fr) 1991-01-12

Family

ID=9383665

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002020794A Abandoned CA2020794A1 (fr) 1989-07-11 1990-07-10 Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament

Country Status (4)

Country Link
EP (1) EP0408444A3 (de)
JP (1) JPH0345601A (de)
CA (1) CA2020794A1 (de)
FR (1) FR2650506B1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2659351B1 (fr) * 1990-03-08 1994-12-02 Pf Medicament Compose polysaccharidique delipide, procede de preparation, compositions en comprenant.
JP7723394B2 (ja) * 2022-03-31 2025-08-14 協和ファーマケミカル株式会社 植物由来有機分子触媒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2396020A1 (fr) * 1977-07-01 1979-01-26 Cassenne Lab Sa Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses d'hafnia, d'aerobacter cloacae et de klebsiella pneumoniae, procede de preparation et application a titre de medicaments de ces produits
FR2540136A1 (fr) * 1983-01-28 1984-08-03 Roussel Uclaf Nouveau procede de preparation d'acylglycoproteines immunostimulantes extraites de klebsiella pneumoniae, compositions pharmaceutiques et procede de lutte contre les maladies allergiques
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
FR2570081B1 (fr) * 1984-09-10 1987-01-09 Pf Medicament Polysaccharides membranaires utiles notamment comme medicament et procede pour leur preparation
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2620130B1 (fr) * 1987-09-08 1990-01-12 Lipha Nouveaux polysaccharides hydrosolubles, leur procede d'obtention, leur application a titre de medicaments et preparation les renfermant

Also Published As

Publication number Publication date
EP0408444A2 (de) 1991-01-16
EP0408444A3 (en) 1991-07-03
JPH0345601A (ja) 1991-02-27
FR2650506A1 (fr) 1991-02-08
FR2650506B1 (fr) 1991-11-08

Similar Documents

Publication Publication Date Title
Cai et al. The secretion of sIgA and dendritic cells activation in the intestinal of cyclophosphamide-induced immunosuppressed mice are regulated by Alhagi honey polysaccharides
EP0001945B1 (de) Polysaccharide extrahiert aus mikrobiellen Zellen von Haemophilus influenzae, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
JPH11500901A (ja) 連鎖球菌属からのリポテイコ酸を含有する抗腫瘍及び抗コレステロール製剤
Jouault et al. Early signal transduction induced by Candida albicans in macrophages through shedding of a glycolipid
FR2490496A1 (fr) Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
EP0015175A1 (de) Arzneimittel mit Gehalt an Pichia oder Pichia-Extrakten
EP0089266B1 (de) Verfahren zur Herstellung von interferoninduzierenden immunostimulierenden Proteoglykanen, die so erhaltenen Proteoglykane und das dieselben enthaltende Arzneimittel
EP0035937A1 (de) Verwendung von Hansenula oder Extrakten von Hansenula als Medikament
CA2063721C (fr) Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae
CA2020794A1 (fr) Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament
BE1004601A3 (fr) Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.
CH669386A5 (de)
CA1117882A (fr) Procede d'obtention d'un nouveau produit biologique et le produit en resultant
Ingólfsdóttir Bioactive compounds from Iceland moss
CH639395A5 (fr) Glycoproteines constitutives d'hafnia, procede de preparation et compositions pharmaceutiques.
EP0286869A1 (de) Verfahren zur Herstellung von Zellwandkomponenten aus Halobakterien und deren Verwendung als Arzneimittel
FR2490495A1 (fr) Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
BE1004569A3 (fr) Exopolymere extracellulaire, son procede de preparation et compositions pharmaceutiques le contenant.
FR2655267A1 (fr) Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
FR2536280A1 (fr) Composition pharmaceutique et procede pour le traitement de tumeurs
JP2002255825A (ja) ジアシルグリセロール誘導体を有効成分とする補体活性化抑制剤および抗炎症剤
JP4165690B2 (ja) インターロイキン１２産生促進組成物の製造方法
CN120943985A (zh) 一种钩藤多糖urp-2及其制备方法和应用
FR2534271A1 (fr) Extrait de micro-organisme soluble dans la pyridine et procede pour son obtention
JP2002212079A (ja) ジアシルグリセロール誘導体を有効成分とするエンドトキシン阻害剤

Legal Events

Date Code Title Description
FZDE Dead